Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

ZIOPHARM Oncology Inc. (ZIOP)

2.52   -0.05 (-1.95%) 09-30 18:14
Open: 2.54 Pre. Close: 2.57
High: 2.67 Low: 2.52
Volume: 1,286,213 Market Cap: 557M
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. The company is headquartered in Boston, Massachusetts and currently employs 48 full-time employees. The firm is focused on developing products in immuno-oncology that employ gene expression, control and cell technologies to deliver cell- and viral-based therapies for the treatment of cancer and graft-versus-host-disease. The company has developed an adenoviral vector, Ad-RTS-IL-12, which is administered intra-tumorally under the control of the RheoSwitch Therapeutic System (RTS) expression platform. Its initial clinical stage product candidate, which is being developed using the immuno-oncology platform is Ad-RTS-IL-12 + veledimex. Ad-RTS-IL-12 + veledimex uses its gene delivery system to produce interleukin-12. As of December 31, 2016, it had completed two Phase II studies evaluating Ad-RTS-IL-12 + veledimex, for the treatment of metastatic melanoma and metastatic breast cancer.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.672 - 2.685 2.685 - 2.696
Low: 2.489 - 2.503 2.503 - 2.514
Close: 2.498 - 2.521 2.521 - 2.539

Technical analysis

as of: 2020-09-30 4:48:19 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 3.23     One year: 3.55
Support: Support1: 2.32    Support2: 1.93
Resistance: Resistance1: 2.76    Resistance2: 3.04
Pivot: 2.62
Moving Average: MA(5): 2.48     MA(20): 2.60
MA(100): 3.02     MA(250): 3.48
MACD: MACD(12,26): -0.09     Signal(9): -0.09
Stochastic oscillator: %K(14,3): 27.55     %D(3): 22.99
RSI: RSI(14): 43.29
52-week: High: 5.61  Low: 1.80  Change(%): -40.7
Average Vol(K): 3-Month: 161910  10-Days: 154884

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ZIOP has closed above bottom band by 35.5%. Bollinger Bands are 11.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 30 Sep 2020
ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Is a Buzzing Hot Stock - Stocks Register

Mon, 28 Sep 2020
ZIOPHARM Oncology Inc. (ZIOP) is on the roll with an average volume of 1.79M in the recent 3 months - The InvestChronicle

Mon, 28 Sep 2020
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) is Holding Steady - The Oracle Dispatch

Mon, 28 Sep 2020
Can ZIOPHARM Oncology Inc. (ZIOP) Remain Competitive? - The News Heater

Wed, 23 Sep 2020
Is ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Popular Amongst Institutions? - Yahoo Finance

Tue, 22 Sep 2020
Short Interest On ZIOPHARM Oncology, Inc. (ZIOP) Might Be Rising - Invest Million

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 214
Shares Float (M) 191
% Held by Insiders 7.12
% Held by Institutions 48.07
Shares Short (K) 31,350
Shares Short P. Month (K) 32,130

Stock Financials

EPS -0.664
EPS Est This Year -0.560
EPS Est Next Year -0.600
Book Value (p.s.) 0.770
Profit Margin
Operating Margin
Return on Assets (ttm) -32.7
Return on Equity (ttm) -112.4
Qtrly Rev. Growth
Gross Profit (p.s.) -0.179
Sales Per Share
EBITDA (p.s.) -0.308
Qtrly Earnings Growth
Operating Cash Flow (M) -46
Levered Free Cash Flow (M) -29

Stock Valuations

PE Ratio -3.80
PEG Ratio
Price to Book value 3.27
Price to Sales
Price to Cash Flow -11.62

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.